Two mechanisms may contribute to elevated SP-D serum levels in pulmonary fibrosis: (1) an absolute increase in alveolar type II epithelial cells due to diffuse hyperplasia increases at the source of pulmonary SP-D; and (2) epithelial injury and basal membrane leakage may cause spillover into the circulation [28]. Here, SFTPD is linked to pulmonary fibrosis.